StockGlow

Quanterix Corporation (QTRX)

Builds machines that detect proteins in blood samples for disease research and diagnostics.

$3.49-0.05%Healthcare
Compare QTRX with
StockGlow Score
43
Neutral
BearishBullish
1 year ago-40.4%

The outlook

Quanterix is trading near the lower end of its 52-week range, with the average analyst price target sitting roughly 24% above the current price of $3.49. Analyst coverage is light at just three analysts, with a consensus rating of Hold, and the stock's price action relative to its moving averages shows mixed signals.

What’s behind the score

Analyst consensusHold — 3.0 avg of 3 analysts
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +24% vs current price

Analyst price target

~12-month · 3 analysts
$4.33average target+24.2% vs now
Now $3.49
Low $4.00High $5.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$164.4M
52-wk high
$8.77
52-wk low
$2.40
50-day avg
$3.49
200-day avg
$4.99
Trailing P/E
—

Similar stocks

SIBNSI-BONE, Inc.$17.93+5.16%KIDSOrthoPediatrics Corp.$19.84+0.10%SEERSeer, Inc.$2.14+8.63%MGTXMeiraGTx Holdings plc$11.82-3.90%REPLReplimune Group, Inc.$5.35-38.01%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy